| Literature DB >> 23388853 |
.
Abstract
Perampanel (Fycompa - Eisai) is a new antiepileptic drug marketed in the EU. It is licensed for use as adjunctive treatment of partial-onset seizuresi with or without secondarily generalised seizures in patients with epilepsy aged 12 years and older.2 Here we discuss the place of perampanel in the treatment of epilepsy.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23388853 DOI： 10.1136/dtb.2013.1.0159
Source DB: PubMed Journal: Drug Ther Bull ISSN： 0012-6543